Investigational Drug Information for L-Phenylalanine
✉ Email this page to a colleague
What is the development status for investigational drug L-Phenylalanine?
L-Phenylalanine is an investigational drug.
There have been 104 clinical trials for L-Phenylalanine.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2001.
The most common disease conditions in clinical trials are Multiple Myeloma, Neoplasms, Plasma Cell, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Fred Hutchinson Cancer Research Center, and M.D. Anderson Cancer Center.
Summary for L-Phenylalanine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,103 |
| WIPO Patent Applications | 2,919 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 3 (2001-02-01) |
| Vendors | 105 |
Recent Clinical Trials for L-Phenylalanine
| Title | Sponsor | Phase |
|---|---|---|
| Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome | Children's Oncology Group | Phase 3 |
| A Study to Give Treatment Inside the Eye to Treat Retinoblastoma | Children's Oncology Group | Phase 2 |
| Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma | ADC Therapeutics | Phase 1 |
Clinical Trial Summary for L-Phenylalanine
Top disease conditions for L-Phenylalanine
Top clinical trial sponsors for L-Phenylalanine
US Patents for L-Phenylalanine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
